HCAR2 and colitis: Sodium butyrate markedly reduces inflammation and improves IECs barrier integrity by activating HCA2 signaling and suppressing the AKT-NF-κB p65 signaling pathway in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis, a model that resembles Crohn's disease (51, 52).